Trastuzumab and lapatinib beyond trastuzumab progression for metastatic breast cancer: strategies and pitfalls
The role of gender in glioblastoma: does it matter?
Azienda USL di Bologna - Alba Brandes, direttore dell'Oncologia dell'Ospedale Bellaria, premiata tra le Top italian women scientists 2016 | Facebook
I farmaci chemioterapici più usati - la Repubblica
I tumori rarissimi al cervello - PressReader
Hakim Rossella, MD, PhD | ior
PDF) Correction to: Which elderly newly diagnosed glioblastoma patients can benefit from radiotherapy and temozolomide? A PERNO prospective study
Donati 8 letti elettrici al reparto di Oncologia del Sistema Nervoso Centrale dell'IRCCS Istituto delle Scienze Neurologiche di Bologna — AUSL di Bologna
The Role of Cetuximab in Pre-Treated Refractory Patients with Metastatic Colorectal Cancer: Outcome Study in Clinical Practice
Postsurgical Approaches in Low‐Grade Oligodendroglioma: Is Chemotherapy Alone Still an Option?
Brain metastases from non-small-cell lung cancer: is there room for improvement?
Cardiovascular Safety of VEGFâ•'Targeting Therapies: Current Evidence and Handling Strategies
Practical Management of Bevacizumab‐Related Toxicities in Glioblastoma
Challenges and progress in the treatment of adult medulloblastomas
Emilia Romagna. Alba Brandes, direttore dell'Oncologia di Bellaria, nella Top Italian Women Scientists 2016 - Quotidiano Sanità
The Effect of Re-operation on Survival in Patients with Recurrent Glioblastoma
PDF) Fotemustine as second-line treatment for recurrent or progressive glioblastoma after concomitant and/or adjuvant temozolomide: A phase II trial of Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)
Treatment options for recurrent glioblastoma: pitfalls and future trends
PDF) Treatment options for recurrent glioblastoma: pitfalls and future trends | Enrico Franceschi - Academia.edu
Hypofractionated Radiotherapy for Pediatric Diffuse Intrinsic Pontine Glioma (DIPG): A Prospective Controlled Randomized Trial
